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Abstract
Whole-body magnetic resonance imaging (MRI) is increasingly being used for a number of indications. Our aim was to review
and describe indications and scan protocols for diagnostic value of whole-body MRI for multifocal disease in children and
adolescents, we conducted a systematic search in Medline, Embase and Cochrane for all published papers until November 2018.
Relevant subject headings and free text words were used for the following concepts: 1) whole-body, 2) magnetic resonance
imaging and 3) child and/or adolescent. Included were papers in English with a relevant study design that reported on the use and/
or findings from whole-body MRI examinations in children and adolescents. This review includes 54 of 1,609 papers identified
from literature searches. Chronic nonbacterial osteomyelitis, lymphoma and metastasis were the most frequent indications for
performing a whole-body MRI. The typical protocol included a coronal STIR (short tau inversion recovery) sequence with or
without a coronal T1-weighted sequence. Numerous studies lacked sufficient data for calculating images resolution and only a
few studies reported the acquired voxel volume, making it impossible for others to reproduce the protocol/images. Only a
minority of the included papers assessed reliability tests and none of the studies documented whether the use of whole-body
MRI affected mortality and/or morbidity. Our systematic review confirms significant variability of technique and the lack of
proven validity of MRI findings. The information could potentially be used to boost attempts towards standardization of
technique, reporting and guidelines development.
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Introduction
Whole-body MRI is a relatively new assessment tool that
allows for imaging of the entire body in one scan, with the
potential to provide both anatomical and functional informa-
tion. Without the use of ionizing radiation, it enables the de-
piction of disease at an early stage, sometimes even before the
onset of clinical symptoms. This ability to detect clinical silent
lesions is often highlighted as an important feature of whole-
body MRI [1–6]. The value of whole-body MRI as an ad-
vanced method to evaluate disease in adults has been investi-
gated by several authors [7–10]; however, the results drawn
from these studies are not directly applicable to children. For
example, when searching for bone diseases, previous research
has shown that MRI findings in the wrist and feet believed to
represent pathology in the mature skeleton merely represent
normal, growth-related changes in children [11–17].
Knowledge of normal signal changes in paediatric bone
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marrow is crucial for the interpretation of whole-body MRI to
avoid false-positive lesions and thereby overstaging of dis-
ease, particularly when searching for clinically silent lesions.
To our knowledge, no studies addressing normal bone mar-
row signal changes on paediatric whole-body MRI have been
published. Moreover, studies addressing the precision, accu-
racy and clinical validity of whole-body MRI in children are
sparse [18].
Despite these shortcomings, whole-body MRI is increas-
ingly being used in children with suspected chronic nonbac-
terial osteomyelitis, Langerhans cell histiocytosis and malig-
nancies, amongst others [19, 20]. Even though the whole-
body MRI protocol should, to some extent, be tailored to the
specific indication, a standard whole-body MRI protocol can
be used for most practical purposes and indications. At least
minimum requirements for parameters (e.g., slice thickness)
can be defined. Protocols seem to vary significantly across
institutions, with respect to sequences, planes and imaging
parameters and there is no uniform or standard protocol for
whole-bodyMRI imaging [19–21]. Further, the nomenclature
regarding anatomical coverage in these examinations is incon-
sistent [20, 22, 23] and a unifying interpretation and reporting
system is lacking.
Several reviews on paediatric whole-body MRI address
potential indications and sequences used [19–21, 24–26],
however, hitherto, no systematic review has been published.
We therefore aimed to provide a systematic review of the
literature to describe common indications and protocols used
to assess multifocal disease, and to examine the diagnostic
value of whole-body MRI in children and adolescents.
Materials and methods
Information sources and search
We conducted literature searches in Medline, Embase and
Cochrane for published papers about whole-body MRI of
children and adolescents until November 2, 2018. Relevant
subject headings and free text words were used for the follow-
ing concepts: 1) whole-body, 2) magnetic resonance imaging
and 3) child and/or adolescent. The detailed search strategies
are given in Online Supplementary Material 1.
Study selection
Title and abstracts of all identified papers were read by two
radiologists (P.Z., a radiology resident, and E.v.B., with 10
years of experience) and checked for eligibility. The selected
papers from this phase plus two papers identified through
other sources were read in full text by the same radiologists
and scored as being eligible for inclusion, not eligible or
uncertain. In cases of disagreement or uncertainty, consensus
was obtained by discussion.
Criteria for inclusion and exclusion
Studies reporting on the use and/or findings from whole-body
MRI examinations to assess multifocal disease in children and
adolescents up to 19 years old were included. For studies
including both children/adolescents and adults, they were in-
cluded if data on at least 10 children/adolescents could be
identifiable separately. Studies written in English and with
the following study designs were included; cross-sectional,
case control, cohorts or randomized controlled trials.
We excluded postmortem studies and whole-body MRI
used for body fat composition, body stature or muscle mass
quantification. Clinical studies using whole-body MRI to
evaluate fat infiltration of muscle, e.g. in neuromuscular dis-
eases, and studies using whole-body MRI angiography or
whole-body integrated MRI/positron emission tomography
(PET) were also excluded.
Data and variables
Information on study and patient characteristics, including meth-
odology and indications for performing whole-body MRI and
the imaging protocol with technical parameters, were extracted
from the included studies. The following technical parameters
were registered: field strength, sequences used, scan plane, slice
thickness, repetition time (TR) and echo time (TE) for T1-
weighted (T1-W), fluid sensitive sequences (T2-weighted/short
tau inversion recovery [STIR]) and diffusion-weighted imaging
(DWI) and inversion time for STIR sequences and b-values for
DWI. If possible, acquired voxel volumes were extracted, either
directly or calculated. The voxel size was calculated from the
field of view (FOV) and the matrix, using a scan percentage of
100%. We sought to extract the acquired voxel volumes, as a
measure for others to repeat the studies. When the FOV was
given as two different values, the highest number was used to
calculate the voxel size in the frequency direction. When the
FOV was given as a range, the mean value was used. We regis-
tered the use of contrast, sedation and anatomical coverage. For
T2-weighted (T2-W), STIR and DWI sequences, we registered
whether motion artefact reduction methods were used. We also
assessed the variation in total scan time and the use of audio or
video during scanning. All included studies were checked for
information about intra- and interobserver agreement and if im-
aging findings were validated. In addition, we registered papers
that mentioned clinically silent lesions (related to expected pa-
thology) and incidental findings (unrelated to known or expected
pathology), and whether the possibility of these findings being
normal variants was discussed. Also registered was whether the
use of whole-bodyMRI affected mortality and/or morbidity. We
also investigated if some studies attempted to establish a standard
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reporting or scoring system for whole-body MRI. Finally, we
registered if a radiologist was amongst the authors and in which
journals the papers were published.
If some of the information we sought was unclear, we tried to
find the missing information from images or figure legends.
When available, supplemental material was read, and additional
information was extracted. Information about the scan parame-
ters and resolutionwas checked against the paper text. The values
were not registered if the information was contradictory.
Statistics
Data were exported into SPSS (Statistical Package version 26;
IBMCorp., Armonk, NY) and cleaned. Frequencies were giv-
en as numbers, with appropriate measures such as percent,
proportions or ratios.
Results
After removing duplicates, 1,357 publications were screened
by reading titles and abstracts. The 128 judged possibly eligi-
ble were read in full text. Of the 54 papers included [1–3, 5, 6,
27–75] (Fig. 1), 78%were published during 2010–18 (Fig. 2).
The majority of included studies (98.2%) focused mainly of
children and adolescents (up to 18 years old). Forty papers
(74.1%) were exclusively about children and adolescents,
and in 13 papers (24.1%) the focus was on both children/
adolescents and adults, but the majority of patients were still
younger than 19 years old. The majority of participants were
adults in only one of the included papers [42].
Study and patient characteristics
Thirty out of the 54 studies (55.6%) had a retrospective design
whilst 24 (44.4%)were prospective. None of the included studies
was a randomised clinical trial. The number of individuals who
underwent one or more whole-bodyMRI in each included paper
varied from 7 to 82 (mean: 26, standard deviation [SD] 17). The
mean age was given in 38 papers, and it ranged from 0 to
19 years; in 24 papers (60.5%), it ranged from 10 to 15 years.
The studies included 1,829 whole-body MRI examinations
(mean: 33, SD 22). Fifteen studies (27.8%) reported on protocols
adjusted to child size, indication, vendor or field strength, and
these protocols were examined separately.
Indications
Based on the included studies, we found chronic nonbac-
terial osteomyelitis (15 papers), lymphoma (8 papers) and
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Fig. 1 Flow diagram for study
exclusion and inclusion
Pediatr Radiol
cancer staging (8 papers) to be the most frequent indica-
tions for performing a whole-body MRI. All examinations
had the purpose of diagnosing and/or evaluating the ex-
tent of disease. In six papers, the indications for the study
participants to undergo whole-body MRI differed, and
were consequently registered as multiple indications
(Table 1). One paper, for example, included cases of
suspected child abuse, chronic nonbacterial osteomyelitis,
lymphoma, osteosarcoma, neuroblastoma and Langerhans
cell histiocytosis [59].
Field strength
Of the 54 studies, 34 (63%) used a 1.5-tesla (T) system only,
while 6 (11%) used 3 T only. Three of the 54 studies (5.5%)
used both 1.5 T and 3 T. Eleven studies did not give any
information on field strength.
Protocol
The typical whole-body MRI protocol included STIR
sequences only (20 papers) [29–32, 38, 39, 41–44, 51, 56,
58, 61, 63, 66–68, 74, 75] or STIR and T1-W sequences (17
papers) [2, 3, 5, 27, 28, 35, 37, 40, 45, 46, 49, 50, 55, 57, 60,
62, 71]. Five studies used a protocol including STIR, T1-W
and DWI [36, 54, 59, 64], and four studies used only STIR
and DWI [52, 53, 69, 70]. In one study, whole-bodyMRI was
performed on equipment from different vendors with different
protocols; the use of STIR was mentioned, but no information
about the use of T1-W or DWI was given [73]. In two studies,
the term STIR only appeared in a legend, and no information
was given on whether the study included T1-W or DWI [1,
72]. In two of the studies, information on sequences was un-
available [6, 65].
Radiofrequency coils
In 9 studies, the body coil was used as the receiver coil. In 18
studies, dedicated surface coils were used. Twenty-seven pa-
pers did not give information on coil type.
Technical settings
Forty-nine out of 54 studies (90.7%) used fluid-sensitive se-
quences, of which 48 used STIR. One of the studies used a
Table 1 Indications for performing whole-body MRI in studies
included in our review
Indication Number of
papers
Chronic nonbacterial osteomyelitis 15
Lymphoma 8
Metastasis 8




Langerhans cell histiocytosis 1
Nonaccidental injury 1
Healthy term infants 1
Sickle cell disease 1
Acute myeloid leukemia 1
Multiple indications in the same paper (i.e. cystic
angiomatosis, Langerhans cell histiocytosis, lymphoma,
neuroblastoma, rhabdomyosarcoma, Ewing tumor,
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Fig. 2 Included papers by year of
publication
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single-shot T2 sequence and three papers did not report on
whether a fluid-sensitive sequence had been used. Thirty-
nine of the 48 studies using STIR performed the scan in the
coronal plane. One study examined protocols from different
institutions, and T2 Dixon/T2 fat saturated was mentioned as
an alternative to STIR, although this was used in only a few
cases [73]. FOV in the feet-head direction varied from 200 to
500 mm per sequence. For papers providing detailed informa-
tion on the technical settings, TR, TE, STIR inversion time
and slice thickness varied substantially (Table 2). Two of the
48 studies (4.2%) using STIR sequences gave the acquired
voxel volume, and for 14 studies (29.2%), this parameter
could be calculated from the FOV and the matrix (as described
in the Materials and methods section).
A T1-W sequence was included in 24 studies (44.4%), of
which 15 (62.5%) were performed in the coronal plane. FOV
in the feet-head direction varied from 265 to 500 mm.
Fourteen of the 24 studies (58.3%) used fast spin-echo se-
quences and the TR, TE and slice thickness varied greatly
amongst these studies (Table 2). In two studies, T1 was per-
formed as a gradient echo sequence. One of the studies (7.1%)
using fast spin-echo sequences reported the acquired voxel
volume; for 6 studies (42.9%), it was calculated.
Ten of the 54 studies (18.5%), all of which were published
after 2012, included a DWI sequence. For 8 of the 10 studies,
DWI was performed in the axial plane. We could not assess
information about the scan plane in the two remaining papers.
In 1 of the 10 papers, the acquired voxel volume was given
and in 3 it could be calculated from the parameters (Table 2).
All 10 studies used more than 1 b-value and the highest b-
value was 1,000.
Contrast enhancement
Five of the included studies used contrast-enhanced sequences
as part of the whole-body MRI protocol [5, 37, 40, 47, 62]. A
sixth study used contrast, but it was unclear whether this was
part of the whole-body protocol [71]. Five of the six used
gadolinium and one study used iron oxide nanoparticles [47].
Sedation and audio/video
In 16 of the 54 studies (29.6%), sedation was given. Eleven
studies did not use sedation and in 27 papers (50%) this infor-
mation was not provided. None of the included papers report-
ed the use of audio or video during the whole-body MRI
examination.
Artefact reduction techniques
Artefact reduction techniques were used in 1 of the 10 proto-
cols with DWI (10%) and in 11 protocols with fluid sensitive
sequences (22.4%). The different artefact reduction tech-
niques were breath-hold and respiratory triggering, electrocar-
diographic gating and buscopan as an antispasmodic agent.
Table 2 Technical parameters at 1.5 T and 3 T used for whole-body MR performed in children and adolescents for various indications, based on a
systematic review of the literature up to November 2018
1.5 T
Range (mean) (SD) (number of papers)
3 T
Range (mean) (SD) (number of papers)
Parameters T2-weighted/STIRa T1-weighted
fast spin echo







































4–6 (4.3) (0.8) (6) 3–8 (5.2) (1.6) (6) 4–5.5 (4.8) (0.8)
(2)












a Combined data from all fluid-sensitive sequences
b Number of papers was one, thus mean and SD could not be calculated
SD standard deviation, STIR short tau inversion recovery
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Scan time
Scan time was defined differently in the studies and varied
between sequence time, totalMRmachine time and time spent
in the department. It was not possible to extract sufficient
information about the length of the individual sequences used.
Body coverage
The whole body from head to toe was included in 32 studies
(59.3%). In nine of the papers, no information on coverage
was given. In the remaining studies (24.1%), the body cover-
age varied from head to pelvis or head to thigh.
Reliability and validation of findings
Ten of the studies (18.5%) performed repeatability tests, of
which 2 studies assessed inter- and intra-observer agreement
[32, 56] and 8 examined for interobserver agreement only [5,
38, 47, 52, 54, 59, 61, 67]. Their results varied depending on
what was assessed from the whole-body MRI. In the two
studies assessing inter- and intra-observer reliability, the
intra-observer agreement was higher than the agreement be-
tween the readers. Two studies looked at interobserver agree-
ment for both nodal and extranodal sites, and scoring of the
nodal sites had a better agreement than the extranodal, includ-
ing bone marrow lesions [52, 54]. Thirty-nine studies (72.2%)
did not perform repeatability tests and in 5 of the 54 included
studies there was no information on inter- and intra-observer
agreement. Thirty-two studies (59.3%) compared whole-body
MRI findings with an established reference standard, i.e.
histology/biopsy (reference standard) and/or observation in-
cluding biopsy and follow-up imaging. Eighteen studies
(33.3%) did not validate their findings. In four studies, no
information on validation was given. None of the studies per-
formed biopsy of all lesions that were scored as pathology on
whole-body MRI.
Interpretation/reporting system
Several of the papers included in this review described the
imaging criteria they used to define pathology. However only
one paper, from 2017 by Arnoldi et al. [28] proposed a stan-
dardized reporting system for whole-body MRI for patients
with chronic nonbacterial osteomyelitis.
Incidental findings, clinically silent lesions and normal
variants
Six papers reported on incidental MR findings [5, 27, 29, 33,
36, 64]. In the study from Anupindi et al. [27], 55 incidental
findings were detected in 23 of 24 patients (96%). None of the
findings was of significant clinical impact requiring imaging
follow-up or treatment. The remaining five papers did not
provide any details on incidental findings.
In 18 of the papers (33.3%), the authors concluded that
whole-body MRI is a sensitive tool for detecting clinically
silent lesions [1–3, 5, 6, 28, 32, 35, 37, 40, 43, 46, 56, 60,
62, 72, 73, 75], of which only 3 papers discussed the possibil-
ity of these findings being due to normal growth related
changes [35, 37, 75]. In total, 12 of 54 papers (22.2%) sug-
gested bone bruise and/or highly cellular bone marrow as a
cause of high signal on T2-W sequences [34, 35, 37, 45, 50,
51, 53, 57–59, 66, 75]. One paper mentioned in a figure leg-
end that diffuse high signal of the bone marrow at DWI is a
normal finding in the spine and pelvis in children [54].
Effect on long-term disease course
None of the included studies addressed whether whole-body
MRI affected long-term disease course (mortality/morbidity).
Authors and journals
Fifty of the 54 papers had a radiologist amongst the authors, in
30 of these (55.6%) as a first author. Sixteen papers (32.7%)
contained sufficient technical parameters for the reader to re-
produce the T2-W/STIR resolution, whereof 14 (87.5%) had a
radiologist as the first author and were published in radiology
journals. In total, 30 of the included papers (55.6%) were
published in radiology journals.
Discussion
Our results show that whole-body MRI is commonly used in
many institutions, particularly to assess chronic nonbacterial
osteomyelitis, lymphoma and malignancy/metastasis.
However, the body area covered, the sequences used and the
technical details vary significantly. More importantly, only a
few studies address the validity of MRI findings.
We found that the term “whole-body MRI” is used inter-
changeably for examinations covering from two-thirds to the
whole body. For instance, whole-body MRI performed for
staging of malignant disease sometimes covers skull-base to
mid-thigh only [42, 52, 54, 67–69], similar to what is often
being used for PET-CT. According to some authors, important
additional clinical information, like therapy-related
osteonecrosis of the knees/ankles [55] or distant metastases
in the extremities [73] could be missed due to this limited
FOV, hence a clear definition of what should be covered in
the scan must be defined when recommending whole-body
MRI for specific diseases. To standardize the nomenclature,
we agree with Greer et al. [25] in defining whole-bodyMRI as
a “multiregional contiguous imaging of the entire body” and
arguing that the term “whole-body MRI” should be reserved
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for “head-to-feet or vertex-to-heel imaging unless otherwise
specified” [23]. Moreover, Greer et al. [23] states that “where
smaller FOV is sufficient, whole-body MRI can be truncated
and should be annotated accordingly.”
The current literature does not allow us to give any prefer-
ences on field strength for whole-body MR imaging in chil-
dren, i.e. whether a 3-T system performs better than a 1.5-T
system. This issue was addressed in one study only including
21 children with different tumors, examined on both 1.5-T and
3-T systems [61]. They found substantial agreement between
two observers, but a better image quality on the 1.5 T, and also
fewer artefacts. They concluded that this difference was un-
likely to be significant as the image quality of the 3-T protocol
was scored high enough. It is, however, difficult to compare
field strength as such because the resultant image also depends
on themachine hardware, software, coil and the protocol used.
Most protocols included coronal STIR and T1-W se-
quences, but the technical settings varied considerably across
institutions. The current use of STIR sequences was not un-
expected, as this is a particularly robust, widely used imaging
method that may improve lesion detection. However, recent
technical improvements have resulted in methods with better
signal to noise ratios, such as T2-Wwith spectral fat saturation
and T2-WDixon, allowing for higher image resolution. In the
present review, only one study mentioned T2-W Dixon, how-
ever, with no elaboration on a potentially added value [73].
The Dixon technique provides images with and without fat
suppression and fat only images, which may replace the T1-
W fast spin echo (FSE) images for bone marrow pathology
[76]. This may reduce examination time, which is particularly
beneficial in children.
One might argue that varying technical settings for the
different pulse sequences, such as TR, TE and image resolu-
tion, is inevitable due to different scanners, indications, coils,
body sizes, etc., and that especially the TR of T2-W/STIR
sequences often is irrelevant. However, we found that TR and
TE times of T2-W/STIR sequences varied significantly
(Table 2), and to such an extent that it might influence image
quality and, more importantly, image analysis. A short TR of
800 ms in a T2-W sequence can result in low signal-to-noise
ratio and additional T1 weighting, while a short TE of 17 ms
in a T2-W sequence gives less T2 and more proton
weighting. The upper range of TE for the T2-W/STIR se-
quences was higher than expected and could result in low
signal-to-noise ratio. This would reduce image resolution
and, consequently, decrease lesion detection. Further, varia-
tion in STIR inversion time influences the degree of fat sup-
pression, whilst high TR times in T1 sequences minimize the
T1 weighting. We believe that defining a size- or weight-
based standard protocol for whole-body MRI within institu-
tions works for most practical purposes and indications. We
also believe that defining standard and/or minimum require-
ments for technical settings, e.g., maximum slice thickness
(3–4 mm depending on patient size or weight) across institu-
tions to ensure sufficient diagnostic quality and to perform
comparative studies, is warranted.
The use of DWI as part of the whole-body MRI has been
addressed in several studies on adults, however, only 10 of the
current studies included a DWI sequence. Five of the studies
assessed a potential added value of DWI in addition to ana-
tomical sequences. Three of these studies concluded that, in
contrast to what has been shown for adults, there was no
significant benefit in diagnostic accuracy from adding DWI
sequences [52, 54, 59]. According to the authors, this could be
related to the small number of patients in the current studies or
to child-specific issues such as smaller body-size or chal-
lenges in interpretation of bone marrow signal in children
due to inhomogeneous DWI signal. Two papers concluded
that DWI could add useful information [53, 69]. The study
by Leclair et al. [53] showed a substantial elevation of the
apparent diffusion coefficient (ADC) values in inflammatory
bone lesions due to chronic recurrent osteomyelitis (chronic
nonbacterial osteomyelitis). Hence, the authors highlighted
DWI as a promising technique that may help to distinguish
benign inflammatory processes from malignant lesions.
However, they only assessed chronic nonbacterial osteomye-
litis lesions. Furthermore, they also mentioned the limitations
of DWI in children due to high bone marrow signals. Punwani
et al. [69] investigated the added value of DWI to PET to
predict local treatment response in children and adolescents
with Hodgkin lymphoma. Pretreatment ADC values in nodal
masses with adequate response were significantly lower than
in sites with inadequate response. Based on their results, the
authors suggested that DWI should be incorporated in inte-
grated PET/MRI protocols [69].
This review revealed inconsistent, and often suboptimal,
reporting of MR technical settings. Most often, a combination
of FOV, imaging matrix and slice thickness was provided. For
some protocols, ranges of FOV and slice thickness were giv-
en, as these parameters were adjusted, according to the region
scanned. Numerous studies lacked sufficient data for calculat-
ing image resolution, making it impossible for the reader to
reproduce the protocol/images. In our opinion, details to as-
sess the acquired voxel size should be provided routinely
when reporting on whole-body MRI. The acquired voxel size
was reported in only a few papers, while from some papers the
reader could deduce the acquired voxel size based on given
parameters, and by an assumption of the scan percentage. We
used a scan percentage of 100% to calculate the in-plane res-
olution, although it is more common to use a scan percentage
of around 80% since this reduces scan time. However, this
means that our calculated voxel sizes can be slightly smaller
than what was used in the protocol, and underestimation of the
resolution was thus avoided.
The voxel size used for the T2-W/STIR sequences varied
by a factor of 20. None of the studies, however, compared the
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effect of different voxel sizes on image quality, or, more im-
portantly, on the imaging findings. One study, however, pro-
posed a high-resolution 3-D STIR scan as the sole sequence,
and compared this to a protocol with both 3-D STIR, T1 and
DWI [59] concluding that the protocols were equally good at
detecting pathology. The technical improvements of MR
equipment, software and coils make it increasingly feasible
to image with higher resolution, although we found no signif-
icant trend when comparing voxel size and year of publica-
tion. It is possible that some sites would rather perform more
sequences, acquisitions in more imaging planes, or shorten
total scan time, rather than choosing a higher resolution scan.
Wewere not able to extract enough information on actual scan
times.
Detailed information on the coils used was sparse. Some
authors used a body coil. Although comfortable for the child,
this coil gives a low signal-to-noise ratio, thus hindering high-
resolution imaging. Dedicated coils, such as phased array coils
allowing for high resolution imaging, were used in several of
the studies. The variety of coils used may, in part, explain the
wide range of image resolution found for all types of
sequences.
Only a few studies reported on child-specific issues such as
the use of sedation and/or motion artefact reducing methods,
be it technical or practical such as watching films or listening
to music. For papers by clinicians in non-radiologic journals
this is understandable, however, many of the radiology-driven
studies also lacked this important information enabling others
to reproduce the examination.
In the adult literature, several studies report on the fre-
quency of incidental whole-body MRI findings [10, 77,
78], but in children this information is sparse. In the cur-
rent review, only one study addressed this issue, reporting
a prevalence of 96% [27]. In general, there is no published
consensus on how to manage incidental findings on whole-
body MRI [10]. Moreover, due to the lack of normal ref-
erence standards for whole-body MRI in children, it may
be difficult to define the findings that have “potential
health or reproductive importance” [79].
Amongst the papers included in the current review, several
concluded that the sensitivity of whole-body MRI for detect-
ing bone-marrow lesions is superior to that of conventional
imaging methods [2, 34, 38, 62, 70]. Further, several authors
emphasized the method’s ability to detect clinically silent le-
sions, thus without discussing the risk of false-positive find-
ings due to growth-related signal variation. Amongst these
were two papers describing any bone marrow hyperintensities
as either related to disease [41] or therapy [43] without giving
their definition of pathology.
The lack of standardized interpretation of whole-bodyMRI
findings may lead to misinterpretation and subsequent conse-
quences for diagnosis and treatment. This is illustrated by the
study of Zibrowska-Bech et al. [3], who retrospectively
evaluated 31 children diagnosed with chronic nonbacterial
osteomyelitis over 10 years [3]. One of the children in the
study was erroneously treated with chemotherapy for 2 weeks
under the suspicion of having osteosarcoma, before the diag-
nosis was changed to chronic nonbacterial osteomyelitis.
Another child had initially been misdiagnosed with
Langerhans cell histiocytosis and was treated with vinblastine
and prednisolone for 6 months before a chronic nonbacterial
osteomyelitis diagnosis. In both cases, there was a substantial
diagnostic delay, ranging from 8.4 months in the first case to
37 months in the second case.
Only a few studies performed reliability tests, but both
papers reporting on inter- and intra-observer agreement
showed a substantially higher score for intra-observer agree-
ment, in part reflecting the lack of definitions for MRI pathol-
ogy. Opposite, the interobserver agreement for evaluating
nodal versus extranodal pathology, clearly defined by interna-
tional standards, was good [52, 54].
Histology was used in 17 studies to validate the accuracy of
the whole-body MRI findings. For obvious reasons, not all
findings on MRI could be biopsied, hence some of the lesions
detected on whole-bodyMRI could still be normal findings or
unrelated to the underlying disease.
There are several limitations to this review. Important
information from non-English publications or from studies
by the clinical site without indexing “whole-body MRI”
may have been missed. Another potential bias is the exclu-
sion of combined adult-paediatric studies with insufficient
information on the included children/adolescents. It was
not possible to extract information about average scan time
due to a lack in data. Lastly, studies listing multiple indi-
cations were registered as “multiple,” thus decreasing
specificity.
Conclusion
Whole-bodyMRI is being used in the pediatric population for
a wide variety of reasons. Chronic nonbacterial osteomyelitis,
lymphoma and metastasis are amongst the most common in-
dications. There is no consensus on a standardized imaging
protocol, and due to insufficient reporting on technical data, a
reproduction of the protocol or images from the published
literature is hardly possible. Furthermore, studies addressing
the precision, accuracy and clinical validity of whole-body
MRI in children are lacking and, to date, there is no document-
ed effect on morbidity and/or mortality. The results from our
study could potentially be used to boost attempts toward stan-
dardization of technique, reporting and guidelines
development.
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